The $1.8bn non-bank lender Liberty Financial has locked in enough support for its initial public offering as its book build is held on Wednesday.
Liberty has secured enough demand to raise at least $321m at $6 per share, equating to 11 times its net profit.
It will list on December 17.
The company was earlier expected to achieve enough demand to cement its float plans, as tipped by DataRoom earlier in the week.
Working on the listing is Credit Suisse, along with retail brokers Evans and Partners and Shaw and Partners.
Market analysts expected much of the stock to be taken up by retail investors, although it is thought that a handful of institutional investors agreed to take small cornerstone stakes in the company, with a 20 per cent interest in the business on offer.
The founder group, excluding Sherman Ma, will sell a 17.6 per cent to 20 per cent interest in their holdings, as Liberty prepares to lodge its prospectus on November 26 with the company to list on December 17.
Healthscope firmly in the sights of Bain
Bain Capital is closing in on its next big target struggling with too much debt – the country’s second-largest hospital operator Healthscope.
Incitec Pivot’s fertiliser price likely too high for some
Potential bidders have been given information about Incitec Pivot’s fertiliser unit, but the jury’s still out as to how much they will be prepared to pay..